In the highly active antiretroviral therapy era, which secondary malignancy to Kaposi sarcoma has emerged as a new risk for patients?
A. Chronic myeloid leukemia
B. Chronic lymphocytic leukemia
C. Acute lymphocytic leukemia
D. Diffuse large B-cell lymphoma
Research published in JAMA Oncology cited cancer of the anus, Hodgkin lymphoma, non-Hodgkin lymphoma, and cancer of the liver as malignancies that have remained associated with Kaposi sarcoma from 1996 to 2013. However, significant associations were also seen for acute lymphocytic leukemia, cancer of the penis, and cancer of the tongue. To read the full study, click here.